C

CITrials | Riverside, CA

Research site

(Unclaimed)

Location

5700 Division Street, Suite 101, Riverside, California, United States of America

Site insights

Top conditions

Top treatments

NaBen®

TNX-102

MK-8189

KarXT

SP-624

SEP-363856

Psilocybin

MK-8189-008

Parent organization

This site is a part of CITrials

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 7 total trials

A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

This is a Phase 2B clinical study evaluating the effectiveness and safety of SP-624 as compared to placebo in the treatment of adults with Major Depr...

Enrolling

Major Depressive Disorder

Drug: SP-624

Drug: Placebo

An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)

This is a Phase 3, multicenter, 56-week, outpatient, open-label (OL) study to evaluate the long-term safety, tolerability, and efficacy of KarXT in d...

Active, not recruiting

Schizophrenia

Drug: Xanomeline and Trospium Chloride Capsules